Correlation Between Vaccinex and Illumina

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vaccinex and Illumina at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vaccinex and Illumina into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vaccinex and Illumina, you can compare the effects of market volatilities on Vaccinex and Illumina and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vaccinex with a short position of Illumina. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vaccinex and Illumina.

Diversification Opportunities for Vaccinex and Illumina

-0.69
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vaccinex and Illumina is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Vaccinex and Illumina in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Illumina and Vaccinex is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vaccinex are associated (or correlated) with Illumina. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Illumina has no effect on the direction of Vaccinex i.e., Vaccinex and Illumina go up and down completely randomly.

Pair Corralation between Vaccinex and Illumina

Given the investment horizon of 90 days Vaccinex is expected to generate 4.12 times more return on investment than Illumina. However, Vaccinex is 4.12 times more volatile than Illumina. It trades about 0.17 of its potential returns per unit of risk. Illumina is currently generating about -0.08 per unit of risk. If you would invest  277.00  in Vaccinex on August 23, 2024 and sell it today you would earn a total of  83.00  from holding Vaccinex or generate 29.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Vaccinex  vs.  Illumina

 Performance 
       Timeline  
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.
Illumina 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Illumina are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy primary indicators, Illumina is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Vaccinex and Illumina Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vaccinex and Illumina

The main advantage of trading using opposite Vaccinex and Illumina positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vaccinex position performs unexpectedly, Illumina can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will offset losses from the drop in Illumina's long position.
The idea behind Vaccinex and Illumina pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum